Escalation phase breakdown The standard protocol starts low and increases every four weeks to minimize gastrointestinal side effects that rapid dose escalation can cause
Proliferation (log 2 doublings, 5 days) of indicated GPX4-deficient cell lines in vitro either untreated or supplemented with cholesterol (5 g/mL), LDL (50 g/mL), HDL (50 g/mL) or Fer-1 (1 M)
For example, the FDA committee members evaluated BPC-157 specifically for ulcerative colitis, but wellness clinics may say simply that BPC-157 is approved, implying that it is approved for everything
3 L-carnitine may also play a role in keeping cholesterol levels in a healthy range
GHK-Cu can be faster for surface injuries
A 90kg researcher who tolerates 4mg easily might escalate to 8mg sooner than a 60kg researcher who experiences significant appetite suppression at 4mg